News
22h
Medical Device Network on MSNDana-Farber develops blood test for multiple myeloma diagnosis
The method assesses growth rates of the tumour and detects gene patterns that can forecast outcomes of the patient.
Farber Cancer Institute have developed a blood test that could transform the diagnosis and monitoring of multiple myeloma (MM) and its precursor conditions. The new method, known as SWIFT-seq, ...
Surface marker analysis by flow cytometry was performed on macrophages treated with 100 μg/mL of secretome for 24 h. We evaluated the percentage of positive macrophages and the mean fluorescence ...
We often use the term “definitive phenotypes” in flow cytometry, which describes the least number of markers to define specific cell populations. Not too long ago, flow cytometry assays were limited ...
Circulating tumor cells (CTCs) are a reliable marker of disease progression in melanoma and can reliably be detected using flow cytometry, suggests a small study of patients with the skin disease ...
The obtained monocyte-macrophage fraction was immunophenotyped by flow cytometry. Isolation of monocytes from peripheral blood Peripheral blood collected from male mice was mixed with equal volume of ...
Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, and an Operating Company of Danaher Corporation, revolutionizes spectral flow cytometry with the industry ...
An AI-enabled microfluidic cytometer could make flow cytometry more accessible, affordable and faster. A research team from George R Brown School of Engineering and Computing (Rice University; TX, USA ...
A technique for the masses: single-cell analysis using mass cytometry Mass cytometry, a technique that bridges the gap between flow cytometry and mass spectrometry, reveals how immune cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results